1. Home
  2. LGCB vs LIXT Comparison

LGCB vs LIXT Comparison

Compare LGCB & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGCB
  • LIXT
  • Stock Information
  • Founded
  • LGCB 2011
  • LIXT 2005
  • Country
  • LGCB Japan
  • LIXT United States
  • Employees
  • LGCB N/A
  • LIXT N/A
  • Industry
  • LGCB
  • LIXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGCB
  • LIXT Health Care
  • Exchange
  • LGCB Nasdaq
  • LIXT Nasdaq
  • Market Cap
  • LGCB 19.7M
  • LIXT 20.5M
  • IPO Year
  • LGCB 2023
  • LIXT N/A
  • Fundamental
  • Price
  • LGCB $1.96
  • LIXT $4.20
  • Analyst Decision
  • LGCB
  • LIXT
  • Analyst Count
  • LGCB 0
  • LIXT 0
  • Target Price
  • LGCB N/A
  • LIXT N/A
  • AVG Volume (30 Days)
  • LGCB 292.1K
  • LIXT 75.1K
  • Earning Date
  • LGCB 07-03-2025
  • LIXT 11-07-2025
  • Dividend Yield
  • LGCB N/A
  • LIXT N/A
  • EPS Growth
  • LGCB N/A
  • LIXT N/A
  • EPS
  • LGCB N/A
  • LIXT N/A
  • Revenue
  • LGCB $8,993,265.00
  • LIXT N/A
  • Revenue This Year
  • LGCB N/A
  • LIXT N/A
  • Revenue Next Year
  • LGCB N/A
  • LIXT N/A
  • P/E Ratio
  • LGCB N/A
  • LIXT N/A
  • Revenue Growth
  • LGCB 5.80
  • LIXT N/A
  • 52 Week Low
  • LGCB $1.22
  • LIXT $0.64
  • 52 Week High
  • LGCB $6.83
  • LIXT $6.26
  • Technical
  • Relative Strength Index (RSI)
  • LGCB 54.90
  • LIXT 45.52
  • Support Level
  • LGCB $1.47
  • LIXT $4.20
  • Resistance Level
  • LGCB $2.25
  • LIXT $4.97
  • Average True Range (ATR)
  • LGCB 0.14
  • LIXT 0.36
  • MACD
  • LGCB 0.06
  • LIXT 0.02
  • Stochastic Oscillator
  • LGCB 68.15
  • LIXT 33.19

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: